Time to treatment benefit for adult patients with Fabry disease receiving agalsidase β: data from the Fabry Registry

X-chromosome inactivation in female patients with Fabry disease

(2015) L. Echevarria et al.   CLINICAL GENETICS

Ten-year outcome of enzyme replacement therapy with agalsidase beta in patients with Fabry disease

(2015) Dominique P Germain et al.   JOURNAL OF MEDICAL GENETICS

Anti-Phospholipase A2 Receptor Antibody Titer Predicts Post-Rituximab Outcome of Membranous Nephropathy

(2015) P. Ruggenenti et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Serum-Mediated Inhibition of Enzyme Replacement Therapy in Fabry Disease

(2015) M. Lenders et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: Data from individual patients and family studies

(2015) Susana Ferreira et al.   MOLECULAR GENETICS AND METABOLISM

Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry Working Group consensus document

(2015) Marieke Biegstraaten et al.   Orphanet Journal of Rare Diseases

UNDERSTANDING AND ANTICIPATING LAG-TIME BIAS IN COST-EFFECTIVENESS STUDIES: THE ROLE OF TIME IN COST-EFFECTIVENESS ANALYSIS

(2015) Gijs van de Wetering et al.   INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE

Enzyme Replacement Therapy Stabilized White Matter Lesion Progression in Fabry Disease

(2014) Andreas Fellgiebel et al.   CEREBROVASCULAR DISEASES

Natural course of Fabry disease and the effectiveness of enzyme replacement therapy: a systematic review and meta-analysis

(2014) Saskia M. Rombach et al.   JOURNAL OF INHERITED METABOLIC DISEASE

Analysis of left ventricular mass in untreated men and in men treated with agalsidase-β: data from the Fabry Registry

(2013) Dominique P. Germain et al.   GENETICS IN MEDICINE

Association Between Urinary Albumin Excretion and Coronary Heart Disease in Black vs White Adults

(2013) Orlando M. Gutiérrez   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Incorporating Lag Time to Benefit Into Prevention Decisions for Older Adults

(2013) Sei J. Lee et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Long-term outcome of enzyme-replacement therapy in advanced Fabry disease: evidence for disease progression towards serious complications

(2013) F. Weidemann et al.   JOURNAL OF INTERNAL MEDICINE

A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance

(2013) L van der Tol et al.   JOURNAL OF MEDICAL GENETICS

Effect of longacting somatostatin analogue on kidney and cyst growth in autosomal dominant polycystic kidney disease (ALADIN): a randomised, placebo-controlled, multicentre trial

(2013) Anna Caroli et al.   LANCET

Long term enzyme replacement therapy for Fabry disease: effectiveness on kidney, heart and brain

(2013) Saskia M Rombach et al.   Orphanet Journal of Rare Diseases

Agalsidase Benefits Renal Histology in Young Patients with Fabry Disease

(2012) C. Tondel et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY

Fabry nephropathy: indications for screening and guidance for diagnosis and treatment by the European Renal Best Practice

(2012) Wim Terryn et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Racial differences in albuminuria, kidney function, and risk of stroke

(2012) O. M. Gutierrez et al.   NEUROLOGY

Fabry-database.org: database of the clinical phenotypes, genotypes and mutant α-galactosidase A structures in Fabry disease

(2011) Seiji Saito et al.   JOURNAL OF HUMAN GENETICS

Cardiovascular Events in Patients With Fabry Disease

(2011) Manesh R. Patel et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Renal outcomes of agalsidase beta treatment for Fabry disease: role of proteinuria and timing of treatment initiation

(2011) D. G. Warnock et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Intensive Diabetes Therapy and Glomerular Filtration Rate in Type 1 Diabetes

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Kidney Function, Albuminuria, and All-Cause Mortality in the REGARDS (Reasons for Geographic and Racial Differences in Stroke) Study

(2010) David G. Warnock et al.   AMERICAN JOURNAL OF KIDNEY DISEASES

Fabry disease

(2010) Dominique P Germain   Orphanet Journal of Rare Diseases

Risk of Recurrent Stroke, Other Vascular Events and Dementia after Transient Ischaemic Attack and Stroke

(2009) Sarah T. Pendlebury et al.   CEREBROVASCULAR DISEASES

Cardiac Microvascular Pathology in Fabry Disease

(2009) Beth L. Thurberg et al.   CIRCULATION

Life expectancy and cause of death in males and females with Fabry disease: Findings from the Fabry Registry

(2009) Stephen Waldek et al.   GENETICS IN MEDICINE

Natural course of Fabry disease: changing pattern of causes of death in FOS - Fabry Outcome Survey

(2009) A Mehta et al.   JOURNAL OF MEDICAL GENETICS

End-stage renal disease in patients with Fabry disease: natural history data from the Fabry Registry

(2009) A. Ortiz et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Stroke in Fabry Disease Frequently Occurs Before Diagnosis and in the Absence of Other Clinical Events

(2009) Katherine Sims et al.   STROKE

Characterization of Fabry Disease in 352 Pediatric Patients in the Fabry Registry

(2008) Robert J Hopkin et al.   PEDIATRIC RESEARCH